AI Medical Technology Doubles Down On Melanoma With Trials And Financing

Is it a mole? Or is it skin cancer? AI Medical Technology's Dermalyser aims to give doctors more confidence when making decisions either way. • Source: Shutterstock
Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Clinical Trials

More from R&D